You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – HalioDx and OSE Immunotherapeutics on Wednesday announced they will conduct a translational investigation to identify potential immune biomarkers for a non-small cell lung cancer treatment.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.